Physician profile
Amanda A Winter
NPI 1518487917
$2,601.35
in general payments reported to CMS, 2019-2025
24 companies · $1,281 in 2025
The $1,281 reported for 2025 was more than what 89% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $831 · 2022: $336 · 2023: $81.02 · 2024: $72.95 · 2025: $1,281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,434.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,179.44 | 2021-2025 | Airsupra, Breztri, Fasenra |
| Actelion Pharmaceuticals US, INC. | $263.40 | 2021-2022 | |
| Genzyme Corporation | $162.16 | 2021-2025 | |
| Glaxosmithkline, LLC. | $152.75 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.54 | 2021-2025 | Jascayd |
| Insmed, INC. | $70.99 | 2025 | Brinsupri, Arikayce |
| Boston Scientific Corporation | $67.99 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $67.50 | 2021-2025 | Dupixent |
| Philips North America LLC | $61.46 | 2025 | Encore |
| Mylan Specialty L.P. | $60.71 | 2021-2024 | Yupelri |
| Electromed, INC. | $49.69 | 2022-2025 | Smartvest |
| Viatris Specialty LLC | $49.30 | 2025 | Yupelri |
| Lilly USA, LLC | $48.79 | 2025 | Zepbound |
| Genentech USA, INC. | $44.18 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $42.23 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $35.20 | 2023 | Inspire |
| Grifols USA, LLC | $30.38 | 2025 | Prolastin-C Liquid |
| Amgen INC. | $29.94 | 2022-2025 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $26.70 | 2023 | |
| United Therapeutics Corporation | $19.38 | 2022 | |
| Baxter Healthcare | $19.12 | 2023 | Hillrom - Life 2000 Ventilation System |
| Novartis Pharmaceuticals Corporation | $16.57 | 2021 | |
| Abbvie INC. | $13.75 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $13.18 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Winter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.